Streetbeat News

Analyst Ratings

TRV

RBC Capital analyst Scott Heleniak maintains a Sector Perform rating on Travelers Companies (NYSE:TRV) and raises the price target from $250 to $273.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 2:05 pm

LYFT

UBS analyst Lloyd Walmsley maintains a Neutral rating on Lyft and raises the price target from $12 to $13.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 2:05 pm

LBRT

Stifel analyst Stephen Gengaro maintains a Buy rating on Liberty Energy (NYSE:LBRT) but lowers the price target from $26 to $25.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 2:04 pm

KTB

UBS analyst Jay Sole maintains a Buy rating on Kontoor Brands (NYSE:KTB) and raises the price target from $90 to $103.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 2:03 pm

HXL

Hexcel (NYSE:HXL) is set to announce its quarterly earnings on October 21, 2024. Analysts expect an EPS of $0.47. The company's past performance shows mixed results, with a recent trend of negative returns over the last year. The consensus rating is Neutral, with a price target suggesting a potential upside. Hexcel's revenue growth is strong, but its gross profit lags behind peers.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 2:03 pm

ISRG

Stifel analyst Rick Wise maintains a Buy rating on Intuitive Surgical (NASDAQ:ISRG) and raises the price target from $475 to $525.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 2:02 pm

MEDP

Medpace Hldgs (NASDAQ:MEDP) is set to release its quarterly earnings on October 21, 2024. Analysts expect an EPS of $2.80. Despite past EPS beats, the stock has shown volatile reactions, with a significant drop after the last earnings report. The stock is up 53.36% over the past year, and analysts have a Neutral consensus with a price target suggesting a 15.37% upside. Medpace shows strong financial metrics compared to peers, with high revenue growth, net margin, and return on equity.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 2:02 pm

ELV

Analysts have mixed views on Elevance Health (NYSE:ELV) with recent ratings showing a slight shift towards bullish sentiment. The average 12-month price target has decreased by 4.8% to $573.91. Analysts have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Elevance Health, a leading U.S. health insurer, has shown strong revenue growth but faces challenges with net margins.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 2:01 pm

QTWO

Q2 Holdings (NYSE:QTWO) has been analyzed by 11 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $82.27, a 23.71% increase from the previous target. Analysts have raised their ratings and price targets, reflecting positive sentiment. However, Q2 Holdings faces challenges with below-average net margin, ROE, ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 2:01 pm

ELS

Equity Lifestyle Properties (NYSE:ELS) is set to release its quarterly earnings on October 21, 2024. Analysts expect an EPS of $0.72. The company's past performance shows mixed reactions to earnings beats, with a focus on future guidance. ELS shares have risen 8.89% over the past year, and analysts have a Neutral rating with a price target of $73.29, indicating a potential 4.51% upside.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 2:01 pm